Found: 27
Select item for more details and to access through your institution.
Transarterial chemoembolization for hepatocellular carcinoma: 2023 Expert consensus-based practical recommendations of the Korean Liver Cancer Association.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 521, doi. 10.3350/cmh.2023.0202
- By:
- Publication type:
- Article
KASL clinical practice guidelines for management of autoimmune hepatitis 2022.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 542, doi. 10.3350/cmh.2023.0087
- Publication type:
- Article
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 593, doi. 10.3350/cmh.2022.0391
- By:
- Publication type:
- Article
Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 605, doi. 10.3350/cmh.2022.0342
- By:
- Publication type:
- Article
Acute hepatitis C virus infection: clinical update and remaining challenges.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 623, doi. 10.3350/cmh.2022.0349
- By:
- Publication type:
- Article
A decade of liver organoids: Advances in disease modeling.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 643, doi. 10.3350/cmh.2022.0428
- By:
- Publication type:
- Article
Acute-on-chronic liver failure: Terminology, mechanisms and management.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 670, doi. 10.3350/cmh.2022.0103
- By:
- Publication type:
- Article
The latest evidence on the impact of fatty liver on liver-related outcomes and mortality in chronic hepatitis B.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 690, doi. 10.3350/cmh.2023.0173
- By:
- Publication type:
- Article
Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 693, doi. 10.3350/cmh.2022.0330
- By:
- Publication type:
- Article
Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 705, doi. 10.3350/cmh.2023.0004
- By:
- Publication type:
- Article
Assessing the performance of ChatGPT in answer- ing questions regarding cirrhosis and hepatocellu- lar carcinoma.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 721, doi. 10.3350/cmh.2023.0089
- By:
- Publication type:
- Article
Classification of microvascular invasion of hepato- cellular carcinoma: correlation with prognosis and magnetic resonance imaging.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 733, doi. 10.3350/cmh.2023.0034
- By:
- Publication type:
- Article
Hepatocellular carcinoma prediction model per- formance decreases with long-term antiviral ther- apy in chronic hepatitis B patients.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 747, doi. 10.3350/cmh.2023.0121
- By:
- Publication type:
- Article
Transarterial radioembolization versus tyrosine ki- nase inhibitor in hepatocellular carcinoma with portal vein thrombosis.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 763, doi. 10.3350/cmh.2023.0076
- By:
- Publication type:
- Article
Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 779, doi. 10.3350/cmh.2023.0110
- By:
- Publication type:
- Article
Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 794, doi. 10.3350/cmh.2023.0057
- By:
- Publication type:
- Article
Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 810, doi. 10.3350/cmh.2023.0129
- By:
- Publication type:
- Article
Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 812, doi. 10.3350/cmh.2023.0132
- By:
- Publication type:
- Article
Letter 1 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrho- sis and hepatocellular carcinoma” .
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 813, doi. 10.3350/cmh.2023.0120
- By:
- Publication type:
- Article
Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma” .
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 815, doi. 10.3350/cmh.2023.0170
- By:
- Publication type:
- Article
Correspondence on Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes” .
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 817, doi. 10.3350/cmh.2023.0155
- By:
- Publication type:
- Article
Correspondence on Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 820, doi. 10.3350/cmh.2023.0135
- By:
- Publication type:
- Article
Correspondence on Letter 1 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 821, doi. 10.3350/cmh.2023.0183
- By:
- Publication type:
- Article
Correspondence on Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 823, doi. 10.3350/cmh.2023.0182
- By:
- Publication type:
- Article
HBeAg-positive grey-zone patients: Treatment be- yond guideline recommendations?
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 825, doi. 10.3350/cmh.2023.0185
- By:
- Publication type:
- Article
Erratum to ‘Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?’.
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 828, doi. 10.3350/cmh.2023.0054e
- By:
- Publication type:
- Article
Erratum to ‘Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in direct acting antiviral failure in South Korea’ [Clin Mol Hepatol 2023;29:496-509].
- Published in:
- Clinical & Molecular Hepatology, 2023, v. 29, n. 3, p. 830, doi. 10.3350/cmh.2022.0345e
- By:
- Publication type:
- Article